Objective: Therapeutic failure of antibiotic therapy has been ascribed to p
harmacokinetic alterations in compromised patient populations. The present
study, therefore, aimed at examining the influences of cardiac surgery and
intensive care procedures on the postoperative target site distribution of
piperacillin. For this purpose, the penetration of piperacillin to the inte
rstitial space fluid, the relevant target site for most bacterial infection
s, was compared between patients after aortic valve replacement and healthy
volunteers.
Design: Comparative study in two study populations.
Setting: The intensive care unit and research ward of a university hospital
.
Patients: The study population included six otherwise healthy patients sche
duled to undergo aortic valve replacement and a control group of six health
y male volunteers.
Interventions: After the administration of a single iv infusion of 4.0 g pi
peracillin, free piperacillin concentrations were measured in the interstit
ium of skeletal muscle and subcutaneous tissue by in vivo microdialysis and
in venous serum. Piperacillin concentrations were assayed with reversed ph
ase high-performance liquid chromatography.
Measurements and Main Results: Interstitial piperacillin concentrations in
muscle and subcutaneous adipose tissue were significantly lower in patients
compared with volunteers with the area under the curve for the interstitiu
m/area under the curve for serum concentration ratios ranging from 0.25 to
0.27 and from 0.43 to 1.22 in patients and volunteers, respectively (p < .0
5 between groups). The terminal elimination half-life was markedly prolonge
d in patients, leading to a concomitant increase in t > minimal inhibitory
concentration (MIC) values, the relevant surrogate for therapeutic success
of therapy with beta-lactam antibiotics, for strains with MIG(50) <4 mu g/m
L. For strains with MIC50 >20 mu l/mL, however, inadequate target site conc
entrations were attained in the patient population.
Conclusions: During the postoperative and intensive care periods, target si
te concentrations of piperacillin are markedly altered and decreased. This
may also be true for other antibiotic agents and may have clinical implicat
ions in that current dosing guidelines may result in inadequate target site
concentrations for high-MIG strains. Conceivably, this could lead to thera
peutic failure in some patients.